InflaRx (IFRX) Non Operating Income (2017 - 2026)

InflaRx's (IFRX) quarterly Non Operating Income came in at -$1.9 million in Q1 2026, up 61.67% year-on-year from -$1.2 million in Q1 2025, and down 172.95% quarter-over-quarter from $2.6 million in Q4 2025.

InflaRx (IFRX) Non Operating Income (2017 - 2026) Analysis & Trends

InflaRx has disclosed Non Operating Income across 10 years of filings, most recently posting -$1.9 million for Q1 2026.

  • Non Operating Income for Q1 2026 came in at -$1.9 million, up 61.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 million (up 267.49% YoY), and the FY2025 annual result was $2.1 million, down 38.05% from the prior year.
  • Non Operating Income came in at -$1.9 million for Q1 2026 at InflaRx, down from $2.6 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $9.3 million in Q4 2023 to a low of -$4.9 million in Q1 2025.
  • The 5-year median for Non Operating Income is -$678124.0 (2022), against an average of $301211.2.
  • Across the five-year window, Non Operating Income soared 2678.88% in 2023 and tumbled 686.06% in 2024, its largest moves.
  • InflaRx's Non Operating Income stood at $334283.0 in 2022, then jumped by 2678.88% to $9.3 million in 2023, then sank by 37.03% to $5.8 million in 2024, then tumbled by 55.68% to $2.6 million in 2025, then tumbled by 172.95% to -$1.9 million in 2026.
  • The last three Non Operating Income figures came in at -$1.9 million (Q1 2026), $2.6 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 5.75 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 444,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - 9.35 Mn
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 -1.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.89 Mn
Dec 31, 2025 2.59 Mn
Sep 30, 2025 3.24 Mn
Jun 30, 2025 1.70 Mn
Mar 31, 2025 -4.93 Mn
Dec 31, 2024 5.85 Mn
Sep 30, 2024 2.29 Mn
Jun 30, 2024 -1.67 Mn
Mar 31, 2024 -3.08 Mn
Dec 31, 2023 9.29 Mn
Sep 30, 2023 -4.03 Mn
Jun 30, 2023 -1.80 Mn
Mar 31, 2023 524,857.71
Dec 31, 2022 334,283.03
Sep 30, 2022 -678,123.97
Jun 30, 2022 -1.66 Mn
Mar 31, 2022 -961,066.77
Dec 31, 2021 2.02 Mn
Sep 30, 2021 -799,145.23
Jun 30, 2021 961,890.13